151
|
Dorban S, Gille M, Kessler R, Piéret F, Declercq I, Sindic CJM. Mouvements choréo-athétosiques et syndrome anti-Hu. Rev Neurol (Paris) 2004; 160:126-9. [PMID: 14978409 DOI: 10.1016/s0035-3787(04)70863-2] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
INTRODUCTION Paraneoplastic choreo-athetoses are rare. We report a case of anti-Hu syndrome with choreo-athetosis. CASE REPORT A 48-year-old woman developed a small-cell lung carcinoma revealed by an anti-Hu syndrome. The neurological features included choreo-athetosis predominating in the upper limbs, chronic sensorimotor axonal polyneuropathy, and opsoclonus. The cerebrospinal fluid was acellular and contained several oligoclonal IgG bands, not found in the corresponding serum. Magnetic resonance imaging revealed bilateral high-intensity lesions on T2/FLAIR sequence in the corona radiata. Moderate transitory improvement of the paraneoplastic neurological syndrome was observed after several carboplatin-etoposid cycles. CONCLUSION A paraneoplastic origin must be considered in all cases of unexplained choreo-athetosis. Paraneoplastic choreo-athetosis is most often associated with other neurological symptoms. The most frequent associated tumor is a small-cell lung carcinoma with anti-CRMP5 and/or anti-Hu antibodies. Our patient developed paraneoplastic choreo-athetosis related to an anti-Hu syndrome in the absence of anti-CRMP5/CV2 antibodies. Paraneoplastic choreo-athetosis might result from a central lesion, and/or from proprioceptive deafferentation subsequent to peripheral neuropathy.
Collapse
|
152
|
Beau-Faller M, Gaub MP, Schneider A, Guérin E, Meyer N, Ducrocq X, Massard G, Gasser B, Kessler R, Weitzenblum E, Wihlm JM, Quoix E, Oudet P. Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression. Eur J Cancer 2003; 39:2538-47. [PMID: 14602140 DOI: 10.1016/s0959-8049(03)00623-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Fibroblast growth factors (FGF), hepatocyte growth factor (HGF) and their receptors, FGFR and c-Met, are essential components of the regulatory networks between the epithelium and mesenchyme in embryonic lung, but their respective roles in tumour growth are not clear. We performed allelotyping at loci containing the candidate genes FGFR-1-2-3-4, FGF-1-2-7-10, c-Met and HGF in 36 non-small cell lung cancer (NSCLC) (20 squamous-cell carcinomas (SQC) and 16 adenocarcinomas (ADC)), by surrounding each locus with two microsatellites (MS), as close as possible to the genes of interest. Unexpectedly, SQC and ADC were frequently altered at all of these loci, and SQC showed more simultaneously altered loci. In ADC, alterations at the 15q13-22 locus (FGF7 candidate gene) were significantly more frequent. Thus, these loci showed different patterns of molecular alterations between SQC and ADC. Finally, alterations at loci containing FGFR and HGF candidate genes were inversely correlated to the lymph node status in SQC and ADC, respectively.
Collapse
|
153
|
Essola B, Remmelink M, Kessler R, Scillia P, Rocmans P. [Primary pulmonary hemangiopericytoma: 2 new cases]. REVUE MEDICALE DE BRUXELLES 2003; 24:408-15. [PMID: 14650317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
We describe two new resected cases of primary pulmonary hemangiopericytoma and the review of cases published in the period 1954-2002. The first patient has a large pulmonary mass of the right apex revealed by scapular pain. The right upper lobectomy with free margins reveals hemangiopericytoma. Pelvic and pulmonary metastases appear two years after surgery, treated by two series of chemotherapy without clinical response. After acute nephrotoxicity controlled by hemodialysis, the patient dies with distant metastases three years and an half after thoracotomy. The second patient develops dry cough and thoracic pain with discovery of a cavitary mass in the right pulmonary field. Fine needle aspiration cytology suggests a mesenchymatous lesion. Three months after extended pneumonectomy, the intrathoracic tumour relapses and regresses partially under chemotherapy. Femoral and brain metastases are irradiated. The patient dies 22 months after thoracotomy. Histology and immunohistochemistry of both tumours closely related to solitary fibrous tumour confirm malignant hemangiopericytoma. Primary pulmonary hemangiopericytoma is rare and may be benign or malignant. Radical resection is the best treatment. Chemotherapy and radiotherapy may improve the prognosis. Compared with lung cancer, the tumour is a slow growing mass, often voluminous, with delayed symptoms, very few lymph node dissemination, rare brain metastasis, more frequent cutaneous or retroperitoneal dissemination, often after long-term and requiring indeed a 10 to 20 years follow-up.
Collapse
|
154
|
Haro JM, Palacín C, Vilagut G, Romera B, Codony M, Autonell J, Ferrer M, Ramos J, Kessler R, Alonso J. [Epidemiology of mental disorders in Spain: methods and participation in the ESEMeD-Spain project]. ACTAS ESPANOLAS DE PSIQUIATRIA 2003; 31:182-91. [PMID: 12838441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
INTRODUCTION The ESEMeD-Spain study is part of a European project on the epidemiology of mental disorders, which is also part of a World Health Organization initiative called World Mental Health Surveys. The main objectives of the study are to estimate the prevalence of mental disorders in Spain; to analyze their association with sociodemographic variables and predisposing and protective factors; to evaluate their impact on the quality of life; and to describe and evaluate the health care received by people with mental disorders. METHODS A representative sample of the noninstitutionalized Spanish population older than 18 years is interviewed. Sample size is 5,500 people. The instrument used in the interviews is the Composite International Diagnostic Interview (CIDI), a questionnaire designed to be used by lay interviewers that allows the diagnosis of psychiatric disorders. Strict quality control of field work has been established. Furthermore, approximately 200 subjects are re-interviewed by a psychiatrist using the Structured Clinical Interview for DSM-IV (SCID) and several questionnaires to measure clinical severity. RESULTS Field work started in September 2001 and finished in November 2002. Up to Ap ril 2002, more than 4,300 people have been interviewed. Preliminary response rate has been 68.7%. Comparison of the age and gender of the study sample with the general Spanish population shows high representativeness. CONCLUSIONS The ESEMeD-Spain project will produce un - precedented scientific information about the epidemiology of mental disorders in Spain.
Collapse
|
155
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Coleman R, Corcoran MD, Cox B, Erwin AR, Escobar CO, Ford R, Glazov A, Golossanov A, Gouffon P, Graham J, Hamm J, Hanagaki K, Hsiung YB, Huang H, Jejer V, Jensen DA, Kessler R, Kobrak HGE, Kotera K, LaDue J, Lai N, Ledovskoy A, McBride PL, Monnier E, Nelson KS, Nguyen H, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Santos E, Senyo K, Shanahan P, Shields J, Slater W, Solomey N, Swallow EC, Taegar SA, Tesarek RJ, Toale PA, Tripathi A, Tschirhart R, Wah YW, Wang J, White HB, Whitmore J, Wilking M, Winstein B, Winston R, Worcester ET, Yamanaka T, Zukanovich RF. Measurements of the Decay KL-->e+ e- mu+ mu-. PHYSICAL REVIEW LETTERS 2003; 90:141801. [PMID: 12731905 DOI: 10.1103/physrevlett.90.141801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/02/2002] [Revised: 02/18/2003] [Indexed: 05/24/2023]
Abstract
The KTeV experiment at Fermilab has isolated a total of 132 events from the rare decay K(L)-->e+ e- mu+ mu-, with an estimated background of 0.8 events. The branching ratio of this mode is determined to be [2.69+/-0.24(stat)+/-0.12(syst)]x10(-9), with a radiative cutoff of M(2)(ee mu mu)/M(2)(K)>0.95. The first measurement using this mode of the parameter alpha from the D'Ambrosio-Isidori-Portolès (DIP) model of the K(L)gamma*gamma* vertex yields a result of -1.59+/-0.37, consistent with values obtained from other decay modes. Because of the limited statistics, no sensitivity is found to the DIP parameter beta. We use this decay mode to set limits on CP and lepton violation.
Collapse
|
156
|
Weitzenblum E, Chaouat A, Charpentier C, Kessler R, Kreiger J. Nocturnal hypoxemia in chronic obstructive pulmonary disease. Sleep 2003. [DOI: 10.1007/978-1-4615-0217-3_44] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
157
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HGE, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Search for the KL-->pi 0 pi 0 e+e- decay in the KTeV experiment. PHYSICAL REVIEW LETTERS 2002; 89:211801. [PMID: 12443402 DOI: 10.1103/physrevlett.89.211801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/11/2001] [Revised: 07/12/2002] [Indexed: 05/24/2023]
Abstract
The recent discovery of a large CP violating asymmetry in KL-->pi+pi-e+e- mode has prompted us to seach for the associated KL-->pi 0 pi 0 e+e- decay mode in the KTeV-E799 experiment at Fermilab. In 2.7 x 10(11) K(L) decays, one candidate event has been observed with an expected background of 0.3 event, resulting in an upper limit for the KL-->pi 0 pi 0 e+e- branching ratio of 6.6 x 10(-9) at the 90% C.L.
Collapse
|
158
|
Weitzenblum E, Chaouat A, Kessler R. [Long-term oxygen therapy for chronic respiratory failure. Rationale, indications, modalities]. REVUE DE PNEUMOLOGIE CLINIQUE 2002; 58:195-212. [PMID: 12407284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Long-term oxygen therapy (LOT) has become quite popular over the last 20 years due to better knowledge of the beneficial effect (improved life expectancy, improved quality of life, stabilization of the pulmonary hypertension) and to technological progress (concentrators, liquid oxygen). Ambulatory techniques have greatly contributed to the widespread use of oxygen therapy as has the decision of the French National Health Insurance System to reimburse this costly treatment. Almost all the studies devoted to the clinical and functional aspects of LOT have concerned patients with chronic obstructive pulmonary disease (COPD). By extension, it is generally accepted that LOT is warranted in other forms of respiratory failure (diffuse fibrosis, cyphoscoliosis, cystic fibrosis, etc.) when blood gas criteria similar to those retained for COPD are present: PaO(2)<=55 mmHg during stable periods with control measurements at lest 3 weeks apart; PaO(2) between 56 and 60 mmHg if there is also an elevated red cell count or pulmonary hypertension, signs of cor pulmonale ou frank hypoxemia during sleep. These consensus indications are widely accepted but other indications remain controversial: should LOT be prescribed for moderate hypoexmia (PaO(2) >=60 mmHg), exercise-induced hyoxemia alone, sleep hypoxemia alone? Appropriate studies are lacking so systematic prescription of LOT cannot be recommended in these three situations. The duration of LOT should be >=16 h/d, and if possible >=18 h/d. It has been established that objective results (life expectancy, improvement in pulmonary hypertension) are better for longer daily treatment. Patient compliance is however often insufficient. In addition to education, the best way to improve patient participation is to strive for improved quality of life with oxygen therapy (portable device, liquid oxygen) in these patients.
Collapse
|
159
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Cunha A, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HGE, LaDue J, Lath A, Ledovskoy A, McBride PL, Medvigy D, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Radiative decay width measurements of neutral kaon excitations using the primakoff effect. PHYSICAL REVIEW LETTERS 2002; 89:072001. [PMID: 12190514 DOI: 10.1103/physrevlett.89.072001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2001] [Indexed: 05/23/2023]
Abstract
We use K(L)'s in the 100-200 GeV energy range to produce 147 candidate events of the axial vector pair K1(1270)-K1(1400) in the nuclear Coulomb field of a Pb target and determine the radiative widths Gamma(K1(1400)-->K0+gamma)=280.8+/-23.2(stat)+/-40.4(syst) keV and Gamma(K1(1270)-->K0+gamma)=73.2+/-6.1(stat)+/-28.3(syst) keV. These first measurements appear to be lower than the quark-model predictions. We also place upper limits on the radiative widths for K(*)(1410) and K(*)(2)(1430) and find that the latter is vanishingly small in accord with SU(3) invariance in the naive quark model.
Collapse
|
160
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HGE, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the K(L) charge asymmetry. PHYSICAL REVIEW LETTERS 2002; 88:181601. [PMID: 12005674 DOI: 10.1103/physrevlett.88.181601] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/31/2001] [Indexed: 05/23/2023]
Abstract
We present a measurement of the charge asymmetry delta(L) in the mode K(L)-->pi(+/-)e(-/+)nu based on 298 x 10(6) analyzed decays. We measure a value of delta(L) = [3322+/-58(stat)+/-47(syst)]x10(-6), in good agreement with previous measurements and 2.4 times more precise than the current best published result. The result is used to place more stringent limits on CPT and DeltaS = DeltaQ violation in the neutral kaon system.
Collapse
|
161
|
Weitzenblum E, Kessler R, Chaouat A. [Alveolar hypoventilation in the obese: the obesity-hypoventilation syndrome]. REVUE DE PNEUMOLOGIE CLINIQUE 2002; 58:83-90. [PMID: 12082446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The obesity-hypoventilation syndrome (or alveolar hypoventilation in the obese) is a new name for an old syndrome, Pickwickian syndrome. It is defined as chronic alveolar hypoventilation (PaO(2)<70 mmHg, PaCO(2) > 45 mmHg) in obese patient with a body mass index > 30 kg/m(2) who have no other respiratory disease explaining the gas anomalies. The large majority of obese subjects are not hypercapnic, even in case of severe obesity. There are three principal causes explaining alveolar hypoventilation in obese subjects: high cost of the work of respiration, dysfunction of the respiratory centers, repeated episodes of nocturnal obstructive apnea. The obesity-hypoventilation syndrome is generally found in males aged over 50 years. Exercise-induced breathlessness is a constant finding. Diagnosis is often made after an episode of severe respiratory failure. Associated diseases favored by obesity are frequent: diabetes, high blood pressure, heart disease. By definition, there is a hypoxemia-hypercapnia syndrome persisting after an acute episode. Spirography usually demonstrates moderate volume restriction. Pulmonary hypertension is frequent but not constant. Obesity-hypoventilation syndrome must be distinguished from obstructive sleep apnea, although the two conditions are often associated. Obstructive sleep apnea may be absent in certain patients with obesity-hypoventilation syndrome (we have had several cases) and inversely, obesity is not observed in certain patients with obstructive apnea. It should be recalled that the term Pickwickian syndrome designates obesity-hypoventilation syndrome (with or without obstructive apnea) and not obstructive sleep apnea syndrome.
Collapse
|
162
|
Dihazi H, Kessler R, Eschrich K. In-gel digestion of proteins from long-term dried polyacrylamide gels: matrix-assisted laser desorption-ionization time of flight mass spectrometry identification of proteins and detection of their covalent modification. Anal Biochem 2001; 299:260-3. [PMID: 11730352 DOI: 10.1006/abio.2001.5376] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
163
|
Dihazi H, Kessler R, Eschrich K. Phosphorylation and inactivation of yeast 6-phosphofructo-2-kinase contribute to the regulation of glycolysis under hypotonic stress. Biochemistry 2001; 40:14669-78. [PMID: 11724581 DOI: 10.1021/bi0155549] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Phosphorylation of yeast 6-phosphofructo-2-kinase and its role for the regulation of glycolysis under hypoosmotic conditions were investigated. 6-Phosphofructo-2-kinase was found to be phosphorylated in vitro by protein kinase C at serine 652 and thereby inactivated. Protein phosphatase 2A reversed the phosphorylative inhibition of the enzyme. When yeast cells were shifted to hypotonic media, 6-phosphofructo-2-kinase was found to be phosphorylated and inactivated. Under in vivo conditions, two phosphate residues were incorporated into the enzyme. One of them is bound to serine 652, indicating that this modification was probably caused by yeast protein kinase C1. The second phosphate is bound to Ser8 within the N-terminal peptide T(1-41) which contains several serine residues but no protein kinase C recognition sequence. Site-directed mutagenesis confirmed that the phosphorylation of serine 652 but not the N-terminal modification is responsible for the in vivo inactivation of 6-phosphofructo-2-kinase. The obtained results suggest that the phosphorylation of 6-phosphofructo-2-kinase mediates a response of the cells to an activation of the hypoosmolarity MAP kinase pathway. Via a suppression of glycolysis, the inactivation of 6-phosphofructo-2-kinase is expected to be responsible for the observed accumulation of glucose 6-phosphate, an essential precursor of the cell wall glucans, and the decrease of glycerol, an important osmolyte.
Collapse
|
164
|
Kessler R, Rodenstein DO. Daytime somnolence. Basic concepts, assessment tools and clinical applications. Monaldi Arch Chest Dis 2001; 56:400-12. [PMID: 11887497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023] Open
Abstract
Excessive somnolence is a common symptom, with a prevalence of 10 to 20% in a general population. However, physicians seldom ask their patients about sleep complaints. The internal biological clock drives the balance between sleepiness and alertness, generating circadian rhythms, with "physiological" increases of somnolence, especially at mid-day and before the habitual bed time. Excessive somnolence is a subjective feeling of an imperious need of sleep in unusual time and environmental conditions. Sleep deprivation, sleep fragmentation and to a lesser degree hypoxia are believed to be the main mechanisms leading to excessive somnolence. Excessive somnolence increases the risk of car accidents, deteriorates health status and quality of life and might increase mortality. Excessive somnolence is associated with many diseases such as obstructive sleep apnoea syndrome. Excessive sleepiness can be assessed by visual scales or questionnaires, the best known being the Epworth sleepiness scale. Objective tests in somnolent patients assess the sleep-wake balance disturbances. The most widely used tests are the multiple sleep latency test (MSLT), the maintenance of wakefulness test (MWT) and the Oxford sleep resistance (OSLER) test. These tests measure the time to sleep emergence in different conditions.
Collapse
|
165
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. First measurement of form factors of the decay Xi(0) --> Sigma(+)e(-)nu macro(e). PHYSICAL REVIEW LETTERS 2001; 87:132001. [PMID: 11580577 DOI: 10.1103/physrevlett.87.132001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2001] [Indexed: 05/23/2023]
Abstract
We present the first measurement of the form factor ratios g(1)/f(1) (direct axial vector to vector), g(2)/f(1) (second class current), and f(2)/f(1) (weak magnetism) for the decay Xi(0)-->Sigma(+)e(-)nu macro(e) using the KTeV (E799) beam line and detector at Fermilab. From the Sigma(+) polarization measured with the decay Sigma(+)-->p pi(0) and the e(-)-nu; correlation, we measure g(1)/f(1) to be 1.32+/-(0.21)(0.17)(stat)+/-0.05(syst), assuming the SU(3)(f) (flavor) values for g(2)/f(1) and f(2)/f(1). Our results are all consistent with exact SU(3)(f) symmetry.
Collapse
|
166
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Qi XR, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Branching ratio measurement of the decay K(L) --> e(+)e(-)mu(+)mu(-). PHYSICAL REVIEW LETTERS 2001; 87:111802. [PMID: 11531512 DOI: 10.1103/physrevlett.87.111802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2001] [Indexed: 05/23/2023]
Abstract
We have collected a 43 event sample of the decay K(L)-->e(+)e(-)mu(+)mu(-) with negligible backgrounds and measured its branching ratio to be (2.62+/-0.40+/-0.17)x10(-9). We see no evidence for CP violation in this decay. In addition, we set the 90% confidence upper limit on the combined branching ratios for the lepton flavor violating decays K(L)-->e(+/-)e(+/-)mu(-/+)mu(-/+) at B(K(L)-->e(+/-)e(+/-)mu(-/+)mu(-/+))< or =1.23x10(-10), assuming a uniform phase space distribution.
Collapse
|
167
|
Breslau N, Johnson EO, Hiripi E, Kessler R. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. ARCHIVES OF GENERAL PSYCHIATRY 2001; 58:810-6. [PMID: 11545662 DOI: 10.1001/archpsyc.58.9.810] [Citation(s) in RCA: 223] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
BACKGROUND The prevalence of smoking in the United States has been closely monitored. However, little is known about the epidemiology of nicotine dependence. We studied DSM-III-R nicotine dependence in the United States, trends across cohorts, and the role of nicotine dependence in smoking persistence. METHODS The Tobacco Supplement to the National Comorbidity Survey was administered to a representative subset of 4414 persons aged 15 to 54 years. The World Health Organization's Composite International Diagnostic Interview was used to assess nicotine dependence. RESULTS Lifetime prevalence of nicotine dependence was 24%, nearly half of those who had ever smoked daily for a month or more. The highest risk for nicotine dependence occurred in the first 16 years after daily smoking began, at which point the rate declined and continued at a slower pace for several years. Nicotine dependence increased the risk of smoking persistence, with an odds ratio (OR) of 2.2 (95% confidence interval [CI], 1.6-3.0). Members of the most recent cohort, who were 15 to 24 years of age at the time of the survey, were the least likely to smoke daily, but those who smoked had the highest risk of dependence: OR for daily smoking in the most recent vs earliest cohort was 0.7 (95% CI, 0.5-0.9), and for dependence among smokers, 7.2 (95% CI, 5.0-10.4). CONCLUSIONS Despite evidence that nicotine dependence is the leading preventable cause of death and morbidity, it remains a common psychiatric disorder. Smoking cessation and the decline in uptake in recent years varied across subgroups of the population.
Collapse
|
168
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the branching ratio and form factor of K(L)-->mu(+)mu(-)gamma. PHYSICAL REVIEW LETTERS 2001; 87:071801. [PMID: 11497879 DOI: 10.1103/physrevlett.87.071801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2001] [Indexed: 05/23/2023]
Abstract
We report on the analysis of the rare decay K(L)-->mu(+)mu(-)gamma the 1997 data from the KTeV experiment at Fermilab. A total of 9327 candidate events are observed with 2.4% background, representing a factor of 40 increase in statistics over the current world sample. We find that B(K(L)-->mu(+)mu(-)gamma) = (3.62 +/- 0.04(stat) +/- 0.08(syst)) x 10(-7). The form factor parameter alpha(K*) is measured to be alpha(K*) = -0.160(+0.026)(-0.028). In addition, we make the first measurement of the parameter alpha from the D'Ambrosio-Isidori-Portolés form factor, finding alpha = -1.54 +/- 0.10. In that model, this alpha measurement limits the Cabibbo-Kobayashi-Maskawa parameter rho>-0.2.
Collapse
|
169
|
Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, Weitzenblum E. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001; 120:369-76. [PMID: 11502631 DOI: 10.1378/chest.120.2.369] [Citation(s) in RCA: 220] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
STUDY OBJECTIVES Obesity has many detrimental effects on the respiratory function and may lead to chronic hypoventilation in some patients, an association known as the obesity-hypoventilation syndrome (OHS). In many cases, patients with OHS also have sleep apneas. Hereafter, we describe several features of a cohort (n = 34) of patients with OHS and show the comparisons with a large cohort (n = 220) of patients with obstructive sleep apnea syndrome (OSAS). We compare also OHS patients with a group of patients with the association of OSAS and COPD, also known as "overlap" patients. DESIGN Descriptive analysis of prospectively collected clinical data. SETTING Respiratory care unit and sleep laboratory of university hospital. RESULTS In OHS patients, OSAS was present in most of the cases (23 of 26 patients). However, in three patients, OHS was not associated with OSAS, showing that obesity per se may lead to chronic hypoventilation. As expected by definition, OHS patients had, on average the worst diurnal arterial blood gas measurements, compared to the other groups. For the OHS patients, the mean diurnal PaO(2) was 59 +/- 7 mm Hg, which was significantly different from the PaO(2) of the OSAS patients (75 +/- 10 mm Hg; p = 0,001) but also from the overlap patients (66 +/- 10 mm Hg; p = 0.015). Pulmonary hypertension (ie, mean pulmonary artery pressure > 20 mm Hg) was more frequent in OHS patients than in "pure" OSAS patients (58% vs 9%; p = 0.001). CONCLUSION Patients with OSAS and chronic respiratory insufficiency had in most cases an associated OHS or COPD. Patients with OHS were older than patients with pure OSAS. They had mild-to-moderate degrees of restrictive ventilatory pattern due to obesity. Severe gas exchange impairment and pulmonary hypertension were quite frequent. The association of OHS and OSAS was the rule. However, in three patients, OHS was not associated with OSAS, suggesting that OHS is an autonomous disease.
Collapse
|
170
|
Dierker LC, Albano AM, Clarke GN, Heimberg RG, Kendall PC, Merikangas KR, Lewinsohn PM, Offord DR, Kessler R, Kupfer DJ. Screening for anxiety and depression in early adolescence. J Am Acad Child Adolesc Psychiatry 2001; 40:929-36. [PMID: 11501693 DOI: 10.1097/00004583-200108000-00015] [Citation(s) in RCA: 135] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To examine the level of diagnostic and discriminative accuracy of three dimensional rating scales for detecting anxiety and depressive disorders in a school-based survey of 9th grade youths. METHOD Classroom screening instruments, the Center for Epidemiologic Studies-Depression Scale (CES-D), the Revised Children's Manifest Anxiety Scale (RCMAS), and the Multidimensional Anxiety Scale for Children (MASC) were administered to 632 youths from three sites in 1998. On the basis of rating scale results, samples of high-scoring and non-high-scoring youths were invited to participate in a diagnostic interview conducted within 2 months of the screening sessions. RESULTS MASC scores were most strongly associated with individual anxiety disorders, particularly among females, whereas the CES-D composite score was associated with a diagnosis of major depression, after controlling for comorbid disorders. The RCMAS was least successful in discriminating anxiety and depression. When receiver operator characteristic curves were examined, diagnostic accuracy was moderate. CONCLUSIONS The ability of the MASC and CES-D to discriminate within and between categorically defined diagnostic groups has important implications for the accurate identification of youths in need of services.
Collapse
|
171
|
Kessler R. CBT added to medical management improved clinical outcomes in rheumatoid arthritis. EVIDENCE-BASED MENTAL HEALTH 2001. [DOI: 10.1136/ebmh.4.3.89] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
172
|
Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducoloné A, Ehrhart M, Oswald-Mammosser M. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164:219-24. [PMID: 11463591 DOI: 10.1164/ajrccm.164.2.2006129] [Citation(s) in RCA: 202] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
The prognostic value and the evolution of pulmonary hypertension (PH) in patients with markedly hypoxemic chronic obstructive pulmonary disease (COPD), treated or not with long-term oxygen therapy (LTOT), has been extensively investigated. However, little is known in patients with mildly or moderately hypoxemic COPD not requiring LTOT. Therefore, we assessed the evolution of pulmonary hemodynamics in 131 patients with stable COPD by performing two right heart catheterizations at a mean (+/- SD) time interval of 6.8 +/- 2.9 yr. At inclusion (T0), no patient had PH (i.e., the mean pulmonary artery pressure [Ppa] at rest was < 20 mm Hg). Group 1 included 55 patients without exercising PH and group 2 included 76 patients with exercising PH, defined by a pulmonary arterial pressure (Ppa) > 30 mm Hg during a steady-state 40-W exercise. Group 2 patients compared with group 1 patients had a significantly higher resting Ppa (16 +/- 3 mm Hg versus 14 +/- 2 mm Hg, p = 0.001). At the second catheterization, 33 (25%) patients (9 of 55 in group 1, 24 of 76 in group 2, p = 0.048) showed a resting Ppa > 20 mm Hg, but PH was generally mild, ranging from 20 to 42.5 mm Hg. The mean Ppa at second evaluation was 16 +/- 5 mm Hg in group 1 and 19 +/- 7 mm Hg in group 2 (p = 0.01). The patients who developed resting PH at the second catheterization (T1) had higher resting and exercising Ppa (p = 0.001 and p = 0.002, respectively), and significantly lower resting and exercising Pa(O(2)) (p = 0.005 and p = 0.012, respectively) at T0. Logistic regression analysis showed that resting and exercising Ppa were independent predictors (at T0) for the subsequent development of PH (p = 0.029 and p = 0.027, respectively). The patients who developed resting PH (T1) had a significantly worsening of Pa(O(2)) (from 63.5 mm Hg at T0 to 60 mm Hg at T1, p = 0.047), whereas the Pa(O(2)) as a mean was stable in the remainder (69.5 mm Hg at T0 and T1). These results show the following. The progression of Ppa over time in patients with COPD with mild to moderate hypoxemia is rather slow, the average change for the group as a whole being of + 0.4 mm Hg/yr. Only about 25% of patients with COPD with mild to moderate hypoxemia and without resting PH at the onset will develop PH during a 6-yr follow-up. The patients with exercising PH at the onset have a significantly increased risk of developing PH over time. Only resting and exercising Ppa at the onset are independently related to the subsequent development of PH. However, in individual cases, the models of linear or logistic regression do not allow a pertinent prediction of the level of Ppa or the presence of PH at the second right heart catheterization.
Collapse
|
173
|
Quoix E, Breton JL, Daniel C, Jacoulet P, Debieuvre D, Paillot N, Kessler R, Moreau L, Coëtmeur D, Lemarié E, Milleron B. Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study. Ann Oncol 2001; 12:957-62. [PMID: 11521802 DOI: 10.1023/a:1011171722175] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND Although the average age of lung cancer patients is increasing, many elderly patients remain undertreated, mainly because of the fear of higher treatment toxicity in this category of patients. We conducted a study to evaluate the efficacy and tolerability of a combination therapy with carboplatin (C) and etoposide phosphate (EP) in elderly patients with Small-Cell Lung Cancer (SCLC). PATIENTS AND METHODS Previously untreated patients older than 70 years with stage IIIB/IV SCLC received a combination of EP (100 mg/m2 D1, D2, D3) and C (D1, dose calculated according to the Calvert formula). Response rate, survival and toxicity were assessed. RESULTS Thirty-eight patients (mean age 76 years, range 70-88 years) received a total of 162 cycles. Eighteen patients (47%) received the six scheduled cycles. Thirty patients were evaluable for efficacy (2 CR and 20 PR). The median survival was 237 days and the one-year probability of survival was 26%. The most common adverse effect was transient grade 3 or 4 neutropenia, observed during 57% of evaluable cycles, while five episodes of febrile neutropenia also occurred, with one fatal (bacteremia). It is noteworthy that no renal or liver toxicity was observed, and no mucitis was noted. Unfortunately, a relatively high proportion of patients died shortly after the start of the study. Although most deaths seemed unrelated to the treatment, the possibility of its exacerbatory effect on comorbidities, especially cardiovascular, cannot be excluded. CONCLUSION The two-drug regimen of carboplatin and etoposide phosphate is feasible in most elderly patients with an acceptable toxicity, and the overall results suggest that patients even older than 70 years may benefit from full treatment. Therefore, consideration should be given to offering active treatment to most patients with SCLC, regardless of age but with special attention paid to comorbidities.
Collapse
|
174
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurements of the rare decay K(L) --> e(+)e(-)e(+)e(-). PHYSICAL REVIEW LETTERS 2001; 86:5425-5429. [PMID: 11415267 DOI: 10.1103/physrevlett.86.5425] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2001] [Indexed: 05/23/2023]
Abstract
We observe 441 K(L)-->e(+)e(-)e(+)e(-) candidate events with a background of 4.2 events and measure B(K(L)-->e(+)e(-)e(+)e(-)) = [3.72+/-0.18(stat)+/-0.23(syst)]x10(-8) in the KTeV/E799II experiment at Fermilab. Using the distribution of the angle between the planes of the e(+)e(-) pairs, we measure the CP parameters beta(CP) = -0.23+/-0.09(stat)+/-0.02(syst) and gamma(CP) = -0.09+/-0.09(stat)+/-0.02(syst). We also present the first detailed study of the e(+)e(-) invariant mass spectrum in this decay mode.
Collapse
|
175
|
Chaouat A, Weitzenblum E, Kessler R, Schott R, Charpentier C, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos Santos J. Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation. Eur Respir J 2001; 17:848-55. [PMID: 11488315 DOI: 10.1183/09031936.01.17508480] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The aim of the present study was to compare the evolution of pulmonary haemodynamics and of arterial blood gases in chronic obstructive pulmonary disease (COPD) patients with mild-to-moderate hypoxaemia, with or without sleep-related oxygen desaturation. COPD patients with daytime arterial oxygen partial pressure in the range 56-69 mmHg were included prospectively. Sleep-related oxygen desaturation was defined as spending > or = 30% of the nocturnal recording time with arterial oxygen saturation <90%. From the 64 patients included, 35 were desaturators (group 1) and 29 were nondesaturators (group 2). At baseline (t0), patients with sleep-related desaturation had a significantly higher daytime (mean +/- SD) arterial carbon dioxide partial pressure (Pa,CO2) (44.9 +/- 4.9 mmHg versus 41.0 +/- 4.1 mmHg, p=0.001) whereas mean pulmonary artery pressure (mPAP) was similar in the two groups. After 2 yrs (t2) of follow-up, 22 desaturators and 14 nondesaturators could be re-evaluated, including pulmonary haemodynamic measurements. None of the nondesaturator patients became desaturators at t2. The difference between the two groups in terms of daytime Pa,CO2 was still present at t2. The mean changes in mPAP from t0 to t2 were similar between the two groups, as were the rates of death or requirement for long-term oxygen therapy (American Thoracic Society criteria) during follow-up of up to 6 yrs. The presence of sleep-related oxygen desaturation is not a transitional state before the worsening of daytime arterial blood gases, but is a characteristic of some chronic obstructive pulmonary disease patients who have a higher daytime arterial carbon dioxide partial pressure. Such isolated nocturnal hypoxaemia or sleep-related worsening of moderate daytime hypoxaemia does not appear to favour the development of pulmonary hypertension, nor to lead to worsening of daytime blood gases.
Collapse
|